The cannabis industry has been experiencing significant changes recently, with Aurora Cannabis announcing plans to reduce debt and interest expenses to achieve positive free cash flow next year. However, this is not the only development that could potentially change the game for Aurora Cannabis and other companies in the sector.On September 8th, the U.S. Drug Enforcement Administration announced a recommendation to potentially reschedule marijuana, which would significantly benefit cannabis companies. The company’s Q1 FY2024 financial report (ending June 30) shows a revenue increase of 50% compared to last year. The company has already taken steps towards achieving profitability, announcing on September 8th that it had bought back an additional CAD 13 million worth of convertible notes. However, much of this growth can be attributed to acquisitions rather than organic factors.Aurora Cannabis had acquired other companies using shares, diluting existing shareholders, and failing to make a significant impact on its overall financial results.
The cannabis industry has been experiencing significant changes recently, with Aurora Cannabis announcing plans to reduce debt and interest expenses to achieve positive free cash flow next year. However, this is not the only development that could potentially change the game for Aurora Cannabis and other companies in the sector.
On September 8th, the U.S. Drug Enforcement Administration announced a recommendation to potentially reschedule marijuana, which would significantly benefit cannabis companies. Furthermore, the U.S. Department of Health and Human Services (HHS) proposed a new...
Read the full article @ Marijuana Index